Company / CapEx per Share
Bio-Rad Laboratories CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$5.40
FY2025
5-year range
$3.74 / $5.56
FY2021-FY2025
Trend
-3.0%
vs FY2024
Sector context
#8 of 148
Health Care
What the data says
Among 148 Health Care companies, Bio-Rad Laboratories is in the top 5% for capex per share. CapEx per Share has fluctuated over the past 10 years, ranging from $3.28 in FY2019 to $5.56 in FY2024.
Based on SEC 10-K filings.
5.40 in FY2025 with a 5-year CAGR of +4.7%. Top quartile in the Health Care sector.
Improved from $5.19 to $5.40 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +13.0%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 148This company $5.40 Sector average $1.67
▼
+222.5% above sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 3.0% year-over-year.
- Ranks #8 out of 148 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2019.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.40 | -3.0% |
| FY2024 | $5.56 | +7.2% |
| FY2023 | $5.19 | +38.7% |
| FY2022 | $3.74 | -15.6% |
| FY2021 | $4.43 | +3.2% |
| FY2020 | $4.29 | +30.9% |
| FY2019 | $3.28 | -31.2% |
| FY2018 | $4.77 | +25.3% |
| FY2017 | $3.81 | -8.3% |
| FY2016 | $4.15 | +7.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026